BRAF V600K vs. BRAF V600E: a comparison of clinical and dermoscopic characteristics and response to immunotherapies and targeted therapies

BACKGROUND: A number of mutations related to malignant melanoma (MM) have been identified, and of the mutated genes, BRAF has been found to be altered in > 50% of cases. Most of these have been BRAF V600E mutations, whereas the incidence of BRAF V600K may vary from 10% to 30%. Little is known abo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zengarini, Corrado, Mussi, Martina, Veronesi, Giulia, Alessandrini, Aurora, Lambertini, Martina, Dika, Emi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311196/
https://www.ncbi.nlm.nih.gov/pubmed/35080260
http://dx.doi.org/10.1111/ced.15113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311196/
https://www.ncbi.nlm.nih.gov/pubmed/35080260
http://dx.doi.org/10.1111/ced.15113

Ejemplares similares